DNB // Back Bay
A unique integrated strategy and corporate and investment banking solution for global and emerging life science and healthcare companies.
The DNB // Back Bay Partnership fortifies companies with financial strategic guidance on growth opportunities across sector and development stage—from private and emerging public life science and healthcare companies seeking partnering, licensing opportunities, M&A opportunities and listing support and execution on U.S. and Nordic exchanges to consolidators seeking and executing on acquisitions and other growth strategies.
We match strategic guidance and capital to develop healthcare assets across the continuum of development within global biopharma, medtech, healthtech and life science companies at every stage and sector.
About the Partnership
The DNB // Back Bay Partnership was formalized in 2023 to provide healthcare companies with strategic guidance, M&A, and partnering support and execution and capabilities in global capital markets and investment and commercial banking. DNB headquartered in Oslo, Norway, and Back Bay Life Science Advisors, headquartered in Boston, Massachusetts, are recognized leaders in global life science development and banking. Together, DNB and Back Bay Life Science Advisors offer unique support to companies along the full continuum of life science and healthcare development.
The DNB // Back Bay Partnership is comprised of dedicated multidisciplinary teams of healthcare experts and corporate and investment bankers who understand the complete picture of asset and company development.
Project Leadership Includes
Jonathan P. Gertler
Co-Founder, Managing Partner & CEO, Back Bay Life Science Advisors
Daniel M. Hochstadt
Location: New York
Managing Director, Head of Investment Banking Americas, DNB Markets Inc.
Global Head of Healthcare, DNB Markets IBD
Location: New York
Head of Healthcare USA, DNB Corporate Banking